CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets First-of-its-kind, cloud-native AI ...

The MarketWatch News Department was not involved in the creation of this content. The clinical data analytics market is experiencing growth due to a rise in chronic diseases. Cloud computing plays a ...

ATLANTIC BEACH, Fla.--(BUSINESS WIRE)--nPhase, Inc., an innovator of cloud-based clinical research technology, today launched REDCap Cloud 2.0, the first industry platform to harmonize real-world ...

Healthcare organizations are investing rapidly in AI and advanced analytics, yet many struggle to translate clinical data into tools that are safe, equitable, and useful in real care settings.

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference ...

Subject to execution of definitive agreements, the data analytics platform is expected to be initially deployed to support a Medicus-sponsored study planned for Q2-Q4 2026, with potential expansion to ...